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The immune response to the synthetic terpolymer L-glutamic acidS°-L-alaninea°-L  - 
tyrosine  1°  (GAT)  is  controlled  by an  H-2-1inked  immune  response  gene.  In  mice 
bearing the H-2  ~' b, d, f, k haplotypes, GAT stimulates antibody formation and primes 
for subsequent T  cell proliferative responses to GAT in Vitro (1,  2). GAT does not 
stimulate  antibody production  or prime  for T  cell-proliferative responses  in  mice 
bearing  nonresponder,  H-2  p'q'a,  haplotypes.  Nevertheless,  nonresponder  mice  can 
develop GAT-specific antibody and T  cell proliferative responses if immunized with 
GAT complexed to methylated bovine serum albumin (MBSA) (GAT-MBSA) (1, 2). 
To date, our studies suggest that the lack of responses to GAT in nonresponder mice 
is a result of the preferential development of GAT-specific suppressor T  cells (3). 
The mechanism(s)  by which  GAT-specific suppressor T  cells regulate immunity 
have been investigated by analysis of T  cell extracts from GAT-primed nonresponder 
mice (4-7). These extracts contain a GAT-specific soluble T  cell suppressor factor(s) 
(GAT-TsF) that mimics the effects of suppressor T  cells by inhibiting development of 
GAT-specific plaque-forming  cell  (PFC)  responses  stimulated  by  GAT-MBSA  in 
nonresponder  mice  in  vivo  and  in  vitro.  Recent  experiments  demonstrated  that 
extracts that contain GAT-TsF also inhibit GAT-specific proliferative responses by T 
cells from GAT-MBSA-primed, nonresponder mice. The materials in the extracts that 
inhibit  PFC and proliferative responses appear to copurify (8). These data suggest 
that  a  single  mediator, or closely related set  of mediators,  can  inhibit  both GAT- 
specific responses. 
Experiments described in  this communication characterize a  monoclonal, GAT- 
specific suppressor factor produced by a hybrid T cell line derived by fusing the HAT- 
sensitive AKR  thymoma, BW5147,  with  splenic T  cells from GAT-primed nonre- 
sponder  DBA/1  (H-2  q)  mice.  This  hybrid  T  cell  line  produces  a  factor  that  is 
representative of the  specific suppressive  material  extracted  from  nonresponder T 
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cells.  More  importantly,  both  GAT-specifie  PFC  and  proliferative  responses  are 
inhibited by this monoclonal T  cell product. 
Materials  and  Methods 
Mice.  DBA/1  (H-2  q)  mice were bred in the animal facilities at The Jewish Hospital (St. 
Louis, Mo.)  and were used when  they were 3-6 mo old. DBA/1  mice are nonresponders to 
GAT. 
Antigens and Immunization.  GAT was purchased from Vega-Fox Biochemicais Div., Newbery 
Energy Corp., Tuseon, Ariz.; MBSA was purchased from Sigma Chemical Co., St. Louis, Mo. 
The insoluble complex, GAT-MBSA, was prepared as previously described (1).  DBA/1  mice 
were injected in the hind footpads with 5-20 btg of GAT as GAT-MBSA emulsified in complete 
Freund's adjuvant that contained Miliary tuberculosis H37Ra. 
Production of T  Cell Hybrid Cell Lines.  DBA/I  mice were injected i.p. with  10 gg of GAT 
mixed with Maalox (Win. H. Rorer, Inc., Fort Washington, Pa.). 4 d later the mice received an 
injection of 2.5 mg of cortisone acetate i.p. (Merck Sharp & Dohme, Div. of Merck & Co., Inc., 
West Point, Pa.), and 3 d later they were sacrificed. Cortisone was injected 4 d after injection 
of GAT because we have found that the concentration of GAT-speeific suppressor T  cells is 
three- to fourfold greater in spleens from these mice compared with spleens from mice injected 
with  GAT alone  (J.  A.  Kapp.  Unpublished observation.). Splenic suppressor T  cells were 
further enriched by filtration through  nylon-wool columns  (9).  The nonadherent  cells were 
fused  with  the  hypoxanthine-guanine phosphoribosyl transferase-deficient AKR  thymoma, 
BW5147,  with  polyethylene glycol  (Carbowax  1,500;  Union  Carbide  Corp.,  Chemicals  & 
Plastics, New York) according to the technique of Galfre et  al.  (10).  Cells were cultured in 
HAT-selection media that contained 10% gamma globulin-free horse serum and 5% calf serum. 
After 3-6 wk, hybrid cell growth was detectable, and supernatant fluids from confluent cultures 
were assayed for suppressor activity (see below). Cells from primary wells that contained GAT- 
specific suppressive activity were cloned by limiting dilution in soft agar over 3T3 feeder layers. 
Isolated colonies were picked, replated in liquid medium, and supernatant  fluids were again 
tested  for suppressive activity. Selected clones have been  maintained  in  tissue culture,  and 
samples of each cell line have been  frozen in  liquid nitrogen. The GAT-specific suppressor 
factor to be described in this communication was produced by clone C4~4, a clone that has 
grown  continuously for 6  mo without  loss  of suppressor activity. This clone also  has  been 
reestablished from  frozen stocks without  diffÉculty or loss of suppressor activity, and,  upon 
recloning, all of the sublines produced suppressor factor. 
Antisera.  Ailoantisera specific for the I  q subregion was prepared by injecting (AQR ×  A)F1 
mice with lymphocytes from B 10.T (6R)  mice, Anti-I-J" was prepared by immunizing [A.TL 
×  B10.S(9R)]F1 mice with B10.HTT lymphocytes. These sera were prepared by Dr. Donald 
Shreffler,  Washington  University  School  of  Medicine  (St.  Louis,  Mo.).  Preparation  and 
characterization of rabbit anti-mouse Ig serum has been described previously (6). 
Preparation and  Use of Immunoadsorbents.  GAT  was  coupled  to  aminohexyl  Sepharose  4B 
(Pharmacia Fine Chemicals, Div. of Pharmaeia, Inc., Piscataway, N. J.)  and  bovine serum 
albumin (BSA), and antibodies were coupled to CNBr-Sepharose 4B as previously described 
(6). Undiluted culture supernates were applied to antigen-coupled Sepharose 4B columns and 
incubated at  4°C  for  1 h.  The  unbound  material was collected, the columns were washed 
extensively, and bound material was eluted with a  discontinuous gradient of 0.5-2.0 M  KCI 
(6).  Material eluted from GAT-Sepharose will be referred to as purified factor. The purified 
factor was diluted 1  : 100 in phosphate-buffered saline that contained 1 mg/ml BSA and applied 
to columns that  contained antibody-coupled Sepharose 4B,  incubated  1 h  at  4°C,  and  the 
unbound material was collected. 
Estimate Molecular Weight.  Supernate from C4#4 was affinity purified and concentrated by 
filtration with  a  YM-10  filter (Amicon Corp.,  Scientific Sys.  Div., Lexington,  Mass.).  The 
concentrated factor was filtered through a Sephacryl G 150 column (Pharmacia Fine Chemicals, 
Div. of Pharmacia, Inc.) that had been calibrated with BSA, ovalbumin, and cytochrome c. 
Cell  Culture and Assay  of Hybrid  T  Cell  Supernates.  Development  of primary splenic  PFC 
responses was measured in vitro under modified Mishell-Dutton conditions previously described 
(1). PFC responses in cultures stimulated with GAT-MBSA or sheep erythrocytes (SRBC) were KAPP, ARANEO, AND CLEVINGER  BRIEF  DEFINITIVE REPORT  237 
assayed on day 5 with GAT-SRBC or SRBC as indicator cells (1). T cell proliferative responses 
to GAT-MBSA by lymph node cells from DBA/1 mice immunized with 5-20 #g of GAT, as 
GAT-MBSA were measured as previously described (2). No differences have been detected in 
proliferative responses or suppressive effects of hybrid T cell supernates between cultures that 
contained unfractionated lymph node cells and nylon wool-enriched  lymph node T  cells (8); 
thus, these cells have been used interchangeably in this report. Incorporation of [aH]thymidine 
([aH]TdR) was measured on day 5. 
Supernatant fluids from hybrid T cell cultures were diluted and added to PFC or proliferation 
cultures  at  initiation.  In  each  experiment, the  relative suppressive  activity of C4~4  was 
determined by titration, and the specificity was verified by addition to cultures stimulated with 
an irrelevant antigen.  Some of the data have been expressed as the inverse of the final dilution 
of supernatant  fluid that  causes  50% suppression  of the response  ($50 U/ml),  Each of the 
experiments reported in this manuscript has been performed several times, and the results were 
highly reproducible.  Therefore, the data presented are from representative experiments. 
Results  and  Discussion 
Suppression of GA T-specific PFC and Proliferative Responses.  Fusion  of T  cells  from 
GAT-primed DBA/1 mice and the AKR thymoma resulted in hybrid cells that grew 
in HAT-selection medium from which three clones that produced specific suppressive 
factor were derived. Supernates from other clones and the thymoma did not inhibit 
in  vitro  responses  when  assayed  at  dilutions  >--1:500, al(hough  dilutions  --<1:50 
frequently augmented  cell  growth  in  culture.  Soluble suppressor  activity of clone 
C4#4  has been characterized and  is  reported here.  Supernatant  fluids  from clone 
C4#4  inhibited GAT-specific PFC responses to GAT-MBSA  (Fig.  1 A)  and GAT- 
specific proliferative responses to GAT  (Fig.  1 B)  in cultures of DBA/1  lymphoid 
cells. 50% inhibition of PFC and proliferative responses was obtained with supernatant 
fluids diluted  1:10,000 to  1:20,000.  This supernate was  a  rich source of suppressor 
factor compared with  extracts of lymphoid cells  from a  single mouse that  usually 
caused 50% inhibition at a dilution "1:500 (4). The suppressive activity was specifi- 
cally removed from  this  supernate  by  filtration  through  GAT-Sepharose columns 
(Fig. 1); none of the activity was absorbed by BSA-Sepharose (not shown). The factor 
absorbed to GAT-Sepharose was eluted with 2.0 M  KCI, and the recovered material 
was enriched in suppressive activity (Fig.  1). Enrichment of suppressive activity has 
been previously observed during affinity purification of extracts (6). The most likely 
explanation for this observation is that both extracts and culture supernates contain 
undefined, nonspecific enhancing materials that compete with GAT-specific suppres- 
sor factors, thereby causing an underestimate of the original suppressive activity. 
Characterization ofMonoclonal GAT-TsF.  To further characterize this hybrid T  cell 
product,  affinity-purified material  was  subsequently  filtered  through  insolubilized 
rabbit anti-mouse Ig or murine alloantisera specific for the I q or I-J  8 subregion. The 
PFC responses to GAT-MBSA and proliferative responses to GAT were specifically 
inhibited by the purified factor, and the suppressive moiety contained determinants 
encoded by the I q subregion but no determinants encoded by Ig-constant region genes 
(Table I). This factor was not bound by antibody directed against the I-J  8 haplotype; 
this  antibody previously has  been shown  to bind  GAT-TsF extracted  from GAT- 
primed B10.S lymphoid cells (8).  Although the I-J subregion of the H-2  q haplotype 
has not been defined by recombination, we assume that the determinants bound by 
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FiG.  1.  Inhibition of GAT-specific responses by culture supernate from clone C4#4. Suppression 
of the PFC response was determined by addition of supernate to cultures that contained normal 
DBA/1  spleen cells that  were stimulated with GAT-MBSA (A).  Suppression of the proliferative 
response was determined by addition of supernate to cultures that contained GAT-MBSA-primed 
DBA/1 lymph node cells stimulated with GAT (B). The responses of culture without supernates are 
shown by the vertical bars; responses in the presence of untreated supernate (H),  supernate 
filtered through GAT-Sepharose (0  C)), and affinity-purified supernate (0---0). 
TABLE I 
Inhibition by Monoclonal GA T-TsF 
C4~4 1:5,000 
Responses 
1g(3 PFC/cuhure*  [ZHITdR ~lcpm$ 
GAT-  SRBC  GAT  MBSA  MBSA 
None  505  600  26,431  89,931 
Purified§  151  540  1,585  78,174 
Purified -.-.} RAM1G [[  49  495  3,856  96,443 
Purified ---} ot-I  q  585  800  21,748  81,195 
Purified ~  a-I-J"  125  650  1,097  75,640 
* PFC responses by spleen cells from normal DBA/I mice. 
:~ Proliferative responses by lymph node cells from GAT-MBSA-primed  DBA/I mice. 
§ Affinity-purified culture supernate. 
H  Rabbit anti-mouse Ig. 
H-28 mice and GT-TsF from H-2  k mice (11)  bear determinants encoded by the I-J 
subregion. 
GAT-TsF from sonicated cells has an estimated 45,000-60,000 mol wt determined 
by Sephadex  chromatography  (6).  Chromatography  of affinity-purified supernate 
from  C4#4  demonstrated  that  all  of the  suppressive  activity  was  contained  in  a 
pooled fraction containing 20,000-  to 60,000-mol wt  proteins  (Table II).  Although 
this was a crude fractionation, the results demonstrated that GAT-TsF extracted from 
lymphoid cells and GAT-TsF isolated from supernatant fluids from hybrid T cells are 
approximately  the  same  size.  This  contrasts  with  the  report  from  Taussig  and 
Holliman  (12)  that demonstrated that a  T  cell hybrid suppressor factor specific for 
SRBC had a >100,000 mol wt. 
From these experiments, we conclude that this cloned T  cell hybrid line produces KAPP, ARANEO, AND CLEVINGER  BRIEF  DEFINITIVE REPORT 
TABL~ II 
Molecular Size of Monoclonal GA T-TsF 
C4¢q.  S~o U/ml* 
Purified:~  1,000,000 
Purified ---* GISO 
Pooled fractions 
80,000-200,1)00  < 1,000 
60,000-80,000  < 1,000 
20,000-60,000  1,300,000 
10,000-20,000  < 1,000 
* Specific suppressive activity determined by inhibition of PFC responses to GAT-MBSA 
in vitro. 
:~ Affinity-purlfied, concentrated supernate, 1.0 ml of which was applied to a Sephacryl 
GIS0 column. 
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a  constitutive, GAT-specific  suppressor  factor that  functionally and  serologically 
resembles GAT-TsF isolated from extracts of  GAT-primed nonresponder T cells. Both 
GAT-specific  PFC  responses  and  GAT-specific  T  cell  proliferative responses  are 
inhibited by this factor. Because this factor was produced in vitro by a cloned hybrid 
T cell line, these data provide evidence that a single mediator, GAT-TsF, is capable 
of inhibiting at least two different GAT-specific responses. We consider the possibility 
that individual hybrid cells produce two functionally  distinct, GAT-specific suppressor 
factors  unlikely, but  proof of a  single  mediator must  await  biochemical analysis. 
Whether the target cell of GAT-TsF in these two assays is the same cell or whether 
GAT-TsF can inhibit multiple T cell subsets is currently under investigation. 
Several  investigators have produced hybrid T  cell  lines  that synthesize antigen- 
specific regulatory factors continuously (12-14), and we anticipate that such cell lines 
will produce enough material for characterization in the near future. We are partic- 
ularly interested in analyzing T  cell  products with  the same antigenic specificity 
derived  from  mice  that  bear  different  H-2  haplotypes  and,  consequently,  bear 
serologically distinct I-J antigens. Comparison of hybrid suppressor  T  cell products 
specific  for GAT and the related copolymer L-glutamic acidS°-L-tyrosine  5° derived 
from several haplotypes is in progress. 
Summary 
The synthetic terpolymer L-glutamic acidS°-L-alaninea°-L-tyrosine  1° (GAT)  stimu- 
lates  GAT-specific  suppressor  T  cells in nonresponder mice.  Extracts from these T 
cells contain a GAT-specific soluble T cell suppressor  factor (GAT-TsF)  that inhibits 
development of GAT-specific  plaque-forming cell  (PFC)  responses  by spleen  cells 
from  nonresponder mice stimulated with  GAT  complexed  to  methylated bovine 
serum  albumin  (GAT-MBSA).  These  extracts  also  contain a  factor that  inhibits 
development of GAT-specific  proliferative responses by GAT-MBSA-primed, nonre- 
sponder lymph node T  cells. Experiments reported in this manuscript show that a 
hybrid T cell line, produced by fusion of the AKR thymoma, BW5147, with spleen 
cells  that  contain GAT-specific  suppressor  T  cells,  produces  a  constitutive GAT- 
specific  suppressor  factor  that  functionally and  serologically  resembles  GAT-TsF 
extracted  from  T  cells. More  importantly,  both  GAT-specific  PFC  and  T  cell 
proliferative responses are inhibited by this factor. 
We  thank  Dr.  Donald Shreffler for the  alloantisera; Isabel Diego, Yvette Fulcher, John 940  KAPP,  ARANEO, AND CLEVINGER  BRIEF  DEFINITIVE REPORT 
Hauenstein,  and  Alexander  Schaeffer  for their  technical  assistance;  Barbara  Wollberg  for 
secretarial assistance;  and Dr. Carl Pierce for his interest and support. 
Received  forpublication 31 March 1980 and in revised  form 28 April 1980. 
References 
1.  Kapp, J. A., C. W. Pierce, and B. Benacerraf.  1973. Genetic control of immune responses 
in vitro. I. Development of primary and secondary plaque-forming cell  responses to the 
random terpolymer L-glutamic acidaO-L-alaninea°-L-tyrosine l° (GAT) by mouse spleen cells 
in vitro.J. Exp. Med.  158:1107. 
2.  Araneo, B. A., and J.  A. Kapp.  1980. H-2-1inked  Ir gene control of T  cell  proliferative 
responses  to the synthetic terpolymer L-glutamic acida°-L-alanineaO-L-tyrosinel°  (GAT). I. 
Requirements for T  cell activation in responder and nonresponder mice. J. Immunol. 124: 
1492. 
3.  Kapp, J.  A., C.  W.  Pierce,  S.  Schlossman, and  B.  Benacerraf.  1974. Genetic control of 
immune responses  in vitro. V. Stimulation of suppressor T  cells in nonresponder mice by 
the terpolymer L-glutamic acide°-L-alaninea°-L-tyrosine 1° (GAT).J. Exp.  Med.  140:648. 
4.  Kapp, J. A., C. W. Pierce, F.  DeLa Croix, and B. Benacerraf.  1976. Immunosuppressive 
factor(s) extracted from lymphoid cell of nonresponder mice primed with L-glutamic acid  e°- 
L-alaninea°-L-tyrosine 1° (GAT). I. Activity and antigenic specificity. J. Immunol. 116:305. 
5.  Kapp, J. A., C. W. Pierce, and B. Benacerraf. 1977. Immunosuppressive factor(s)  extracted 
from lymphoid cells  of nonresponder mice primed  with  L-glutamic acide°-L-alaninea°-L - 
tyrosine  l° (GAT). II. Cellular source and effect  on responder and nonresponder mice. J. 
Exp. Med.  145:828. 
6.  Theze, J., J.  A.  Kapp,  and  B.  Benacerraf.  1977. Immunosuppressive factor(s)  extracted 
from lymphoid cells  of nonresponder  mice primed  with  L-glutamic acid6°-L-alaninea°-L - 
tyrosine  1° (GAT). III. Immunochemical properties of the GAT-specific suppressive factor. 
J. Exp. Med.  145:839. 
7.  Kapp, J. A.  1978. Immunosuppressive factors from lymphoid cells of nonresponder mice 
primed with L-glutamic acide°-L-alaninea°-L-tyrosine  1°. IV. Lack of  strain restrictions among 
allogeneic, nonresponder donors and recipients.J.  Exp.  Med.  147:997. 
8.  Araneo,  B.  A.,  and  J.  A.  Kapp.  Immunosuppressive  factor(s)  from  lymphoid  cells  of 
nonresponder mice primed with L-glutamic acida°-L-alaninea°-L-tyrosine  l° (GAT). V. Inhi- 
bition of T cell proliferative responses. J. Immunol. In press. 
9. Julius, M. H., E. Simpson, and L. A. Herzenberg.  1973. A rapid method for the isolation 
of functional thymus derived murine lymphocytes. Eur. J. Immunol. 3:64.5. 
10.  Ga!fre, G., S. C. Howe, C. Milstein, G. W. Butcher, andJ. C. Howard. 1977. Antibodies to 
major histocompatibility antigens produced by hybrid cell lines. Nature (Lond.).  266:550. 
11.  Germain, R. N., J. Theze, C. Waltenbaugh, M. E. Dorf, and B. Benacerraf.  1978. Antigen- 
specific  T  cell mediated suppression. II. In vitro induction by I-J coded L-glutamic acid  5°- 
L-tyrosine 5°  (GT)-specific T  cell  suppressor  factor  (GT-TsF)  of suppressor T  cells  (Ts2) 
bearing distinct I-J determinants.].  Immunol. 121:602. 
12.  Taussig, M. J., and A. Holliman.  1979. Production of an H-2-related suppressor factor by 
a hybrid T cell line. Nature (Lond.).  277:305. 
13.  Taniguchi,  M.,  and J.  F.  A.  P.  Miller.  1978. Specific suppressive  factors  produced  by 
hybridomas derived from the fusion of enriched suppressor T cells and a T  lymphoma cell 
line.J.  Exp. Med.  148:373. 
14.  Kontiainen,  S.,  E.  Simpson,  E.  Bohrer,  P.  C.  L.  Beverley,  L.  A.  Herzenberg,  W.  C. 
Fitzpatrick, P. Vogt, A. Torano, I. F. C. McKenzie, and M. Feldman.  1978. T  cell  lines 
producing antigen-specific suppressor factor. Nature (Lond.).  274:477. 